194
Views
1
CrossRef citations to date
0
Altmetric
Review

Prevention and treatment of temporal lobe epilepsy: lessons from hepatitis B story!

&
Pages 1151-1155 | Received 19 Oct 2019, Accepted 04 Feb 2020, Published online: 27 Feb 2020

References

  • Engel J, Jr, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307(9):922–930.
  • Wiebe S. Epidemiology of temporal lobe epilepsy. Can J Neurol Sci. 2000; 27(01):S6–S10.
  • Asadi-Pooya AA, Stewart GR, Abrams DJ, et al. Prevalence and incidence of drug-resistant mesial temporal lobe epilepsy in the United States. World Neurosurg. 2017; 99:662–666.
  • Asadi-Pooya AA, Rostami C. History of surgery for temporal lobe epilepsy. Epilepsy Behav. 2017; 70:57–60.
  • Asadi-Pooya AA, Nikseresht AR, Yaghoobi E, et al. Physical injuries in patients with epilepsy and their associated risk factors. Seizure. 2012;21(3):165–168.
  • Sperling MR, Barshow S, Nei M, et al. A reappraisal of mortality after epilepsy surgery. Neurology. 2016;86(21):1938–1944.
  • Bartolini L, Theodore WH, Jacobson S, et al. Infection with HHV-6 and its role in epilepsy. Epilepsy Res. 2019; 153:34–39.
  • Wipfler P, Dunn N, Beiki O, et al. The viral hypothesis of mesial temporal lobe epilepsy - is human herpes virus-6 the missing link? A systematic review and meta-analysis. Seizure. 2018; 54:33–40.
  • Ablashi D, Agut H, Alvarez-Lafuente R, et al. Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol. 2014;159(5):863–870.
  • Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med. 2005;352(8):768–776.
  • Yao K, Crawford JR, Komaroff AL, et al. Review part 2: human herpesvirus-6 in central nervous system diseases. J Med Virol. 2010;82(10):1669–1678.
  • Engdahl E, Dunn N, Niehusmann P, et al. Human herpesvirus 6 B induces hypomethylation on chromosome 17p13.3, correlating with increased gene expression and virus integration. J Virol. 2017; 91:e02105–16.
  • Bartolini L, Libbey JE, Ravizza T, et al. Viral triggers and inflammatory mechanisms in pediatric epilepsy. Mol Neurobiol. 2019;56(3):1897–1907.
  • Shukla G, Prasad AN. Natural history of temporal lobe epilepsy: antecedents and progression. Epilepsy Res Treat. 2012; 2012:195073.
  • Bartolini L, Piras E, Sullivan K, et al. Detection of HHV-6 and EBV and cytokine levels in saliva from children with seizures: results of a multi-center cross-sectional study. Front Neurol. 2018; 9:834.
  • Epstein LG, Shinnar S, Hesdorffer DC,. et al. Human herpesvirus 6 and 7 in febrile status epilepticus: the FEBSTAT study. Epilepsia. 2012;53(9):1481–1488.,
  • Asadi-Pooya AA, Nei M, Rostami C, Sperling MR. Mesial temporal lobe epilepsy with childhood febrile seizure. Acta Neurol Scand. 2017;135(1):88–91.
  • Makvandi M. Update on occult hepatitis B virus infection. World J Gastroenterol. 2016;22(39):8720–8734.
  • Whitford K, Liu B, Micallef J, et al. Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis. Bull World Health Org. 2018;96(7):484–497.
  • Leoni MC, Ustianowski A, Farooq H, et al. HIV, HCV and HBV: a review of parallels and differences. Infect Dis Ther. 2018;7(4):407–419.
  • Tang LSY, Covert E, Wilson E, et al. Chronic hepatitis B infection: a review. JAMA. 2018;319(17):1802–1813.
  • Suk-Fong Lok A. Hepatitis B treatment: what we know now and what remains to be researched. Hepatol Commun. 2019;3(1):8–19.
  • Li W, Li L, Han J, et al. Liver transplantation vs liver resection in patients with HBV-related hepatocellular carcinoma beyond Milan criterion: a meta-analysis. Clin Transplant. 2018;32(3):e13193.
  • Ferrarese A, Zanetto A, Russo FP. Hepatitis B and liver transplantation. Minerva Gastroenterol Dietol. 2018;64(2):147–157.
  • Nagamata S, Aoshi T, Kawabata A, et al. Identification of CD4 and H-2K(d)-restricted cytotoxic T lymphocyte epitopes on the human herpesvirus 6B glycoprotein Q1 protein. Sci Rep. 2019;9(1):3911.
  • Agut H, Bonnafous P, Gautheret-Dejean A. Laboratory and clinical aspects of human herpesvirus 6 infections. Clin Microbiol Rev. 2015;28(2):313–335.
  • Milbradt J, Auerochs S, Korn K, et al. Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate. J Clin Virol. 2009;46(1):24–28.
  • Hattiangady B, Shetty AK. Neural stem cell grafting in an animal model of chronic temporal lobe epilepsy. Curr Protoc Stem Cell Biol. 2011; 2: 2D.7.
  • Hlebokazov F, Dakukina T, Ihnatsenko S, et al. Treatment of refractory epilepsy patients with autologous mesenchymal stem cells reduces seizure frequency: an open label study. Adv Med Sci. 2017;62(2):273–279.
  • You SJ. Human herpesvirus-6 may be neurologically injurious in some immunocompetent children. J Child Neurol. 2020;35:132–136. Oct 21. [Epub ahead of print].
  • Stevanović V, Barušić Z, Višković K, et al. Acute necrotizing encephalopathy of childhood associated with human herpes virus 6 in Croatia. Neurol Sci. 2019;40(3):639–641.
  • Tsukahara A, Nakajima H, Hosokawa T, et al. Human herpes virus 6 brainstem encephalitis in a patient with primary macroglobulinemia. Neurol Sci. 2017;38(3):507–508.
  • Esposito L, Drexler JF, Braganza O, et al. Large-scale analysis of viral nucleic acid spectrum in temporal lobe epilepsy biopsies. Epilepsia. 2015;56(2):234–243.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.